Picture of Barinthus Biotherapeutics logo

BRNS — Barinthus Biotherapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Vaccitech Reports First Quarter 2023 Financial Results

May 12 (Reuters) - Vaccitech PLC  VACC.O :
    * VACCITECH REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND
RECENT CORPORATE DEVELOPMENTS
    * VACCITECH PLC Q1 REVENUE $500,000
    * VACCITECH PLC - EXPECT OUR CASH RUNWAY TO FUND OUR
OPERATING
EXPENSES AND CAPITAL EXPENDITURE REQUIREMENTS INTO Q1 OF 2025
    * VACCITECH PLC - AS OF MARCH 31, 2023, CASH WAS $191.3
MILLION,
COMPARED TO $194.4 MILLION AS OF DECEMBER 31, 2022
    * VACCITECH PLC - QTRLY LOSS PER SHARE $0.48

Source text for Eikon:  ID:nGNX4pmmcb 
Further company coverage:  VACC.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Barinthus Biotherapeutics

See all news